======= ACSM1 ======= == Gene Information == * **Official Symbol**: ACSM1 * **Official Name**: acyl-CoA synthetase medium chain family member 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=116285|116285]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q08AH1|Q08AH1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ACSM1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ACSM1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/614357|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Has medium-chain fatty acid:CoA ligase activity with broad substrate specificity (in vitro). Acts on acids from C(4) to C(11) and on the corresponding 3-hydroxy- and 2,3- or 3,4- unsaturated acids (in vitro). Functions as GTP-dependent lipoate- activating enzyme that generates the substrate for lipoyltransferase (By similarity). {ECO:0000250}. |AMP-binding| |benzoate metabolic process| |butyrate metabolic process| |fatty acid ligase activity| |fatty-acyl-CoA synthase activity| |butyrate-CoA ligase activity| |acyl-CoA ligase activity| |short-chain fatty acid metabolic process| |benzene-containing compound metabolic process| |fatty acid oxidation| |lipid oxidation| |cholesterol homeostasis| |sterol homeostasis| |thioester metabolic process| |acyl-CoA metabolic process| |antibiotic metabolic process| |fatty acid biosynthetic process| |xenobiotic metabolic process| |ribonucleoside bisphosphate metabolic process| |nucleoside bisphosphate metabolic process| |purine nucleoside bisphosphate metabolic process| |lipid homeostasis| |blood microparticle| |monocarboxylic acid biosynthetic process| |cellular response to xenobiotic stimulus| |lipid modification| |energy derivation by oxidation of organic compounds| |coenzyme metabolic process| |response to xenobiotic stimulus| |carboxylic acid biosynthetic process| |organic acid biosynthetic process| |purine ribonucleotide metabolic process| |fatty acid metabolic process| |ribonucleotide metabolic process| |purine nucleotide metabolic process| |ribose phosphate metabolic process| |sulfur compound metabolic process| |purine-containing compound metabolic process| |mitochondrial matrix| |GTP binding| |generation of precursor metabolites and energy| |cofactor metabolic process| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |drug metabolic process| |monocarboxylic acid metabolic process| |nucleobase-containing small molecule metabolic process| |lipid biosynthetic process| |small molecule biosynthetic process| |cellular amide metabolic process| |organophosphate metabolic process| |carboxylic acid metabolic process| |cellular lipid metabolic process| |oxidation-reduction process| |oxoacid metabolic process| |organic acid metabolic process| |carbohydrate derivative metabolic process| |chemical homeostasis| |lipid metabolic process| |ATP binding| |homeostatic process| |small molecule metabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp116|AICAR 240μM R03 exp116]]|-2.14| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|1.7| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4919 * **Expression level (log2 read counts)**: -4.27 {{:chemogenomics:nalm6 dist.png?nolink |}}